BIOLASE Manager, Robert Malak, Receives AppSheet Innovator Award
Biolase, Inc. (BIOL)
Last biolase, inc. earnings: 3/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
biolase.com/investors
Company Research
Source: PR Web
SEATTLE (PRWEB) June 14, 2018 BIOLASE Manager of Financial Planning and Analysis (FP&A), Robert Malak receives AppSheet's Innovator award, an award that recognizes app creators for creating apps that change how work is done, influencing positive changes in organizations and the world. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including CAD/CAM scanners. As the Manager of FP&A, Malak created a complex app that took the sales process to the next level by eliminating paper and allowing payments to be processed in real-time. "When I saw that my spreadsheets were getting butchered by my team's mobile devices, I started looking for an alternative solution," said Malak . "I had a friend that recommended AppSheet. That's when I learned that anybody can develop an app and potentially replace their spreadsheets with it."AppSheet's App Innova
Show less
Read more
Impact Snapshot
Event Time:
BIOL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIOL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIOL alerts
High impacting Biolase, Inc. news events
Weekly update
A roundup of the hottest topics
BIOL
News
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Benchmark Co. from $2.50 to $0.40. They now have a "speculative buy" rating on the stock.MarketBeat
- Thinking about buying stock in Xpeng, Ocugen, Quantum Computing, CONSERVATIVE BROADCAST MEDIA JOURNALISM, or BIOLASE?PR Newswire
- Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M [Seeking Alpha]Seeking Alpha
BIOL
Sec Filings
- 3/27/24 - Form S-1/A
- 3/22/24 - Form DEFA14A
- 3/22/24 - Form DEF
- BIOL's page on the SEC website